13F
← All fund report cards

PZENA INVESTMENT MANAGEMENT LLC

13F equity value
$30.8B
Positions
158
Top 10 concentration
35.7%
Quarters / total new picks
32 / 284
13F equity value over time
$0M$17B$33B2017201820192020202120222023202420252026

"13F equity value" = market value of this filer's US-listed long equity positions only. It excludes cash, bonds, non-US and short positions, so it understates a fund's true assets under management — often by a lot.

Not significant Verdict

13F holdings are disclosed ~45 days after quarter-end, and they never reveal when within the quarter a fund actually bought. So any 13F-based summary is structurally late and blurred — this applies to every fund, including this one.

We backtested copying it anyway. Buying this fund's new positions the day each filing went public, over 32 quarters, returned +2.7% per quarter — versus +2.7% per quarter from simply owning every 13F stock. It beat that baseline in only 40.6% of quarters (excess t = -0.22, not statistically significant). Its filings tell you what it bought — not what you should buy.

Avg 2Q excess
-0.3%
t-stat
-0.22
Quarterly win rate
41%
Annualized excess
-0.2%
$1 → follow vs universe
$2.06 vs $2.09
Cumulative return: $1 invested in new picks vs universe
1.00 20180331: universe 1.04120180630: universe 0.95920180930: universe 1.00320181231: universe 0.99220190331: universe 0.97520190630: universe 1.04820190930: universe 1.12720191231: universe 0.90920200331: universe 1.09620200630: universe 1.21120200930: universe 1.48520201231: universe 1.55320210331: universe 1.56620210630: universe 1.69220210930: universe 1.51920211231: universe 1.29220220331: universe 1.38720220630: universe 1.28520220930: universe 1.38120221231: universe 1.28220230331: universe 1.35120230630: universe 1.30320230930: universe 1.47920231231: universe 1.54520240331: universe 1.58020240630: universe 1.72320240930: universe 1.70820241231: universe 1.59420250331: universe 1.73820250630: universe 1.79320250930: universe 2.01620251231: universe 2.085 20180331: follow 1.14620180630: follow 1.06820180930: follow 1.12120181231: follow 1.09120190331: follow 1.01420190630: follow 1.01120190930: follow 1.05720191231: follow 0.83320200331: follow 0.94120200630: follow 1.03720200930: follow 1.08720201231: follow 1.33920210331: follow 1.61720210630: follow 1.72120210930: follow 1.73820211231: follow 1.56720220331: follow 1.57920220630: follow 1.58220220930: follow 1.70620221231: follow 1.69120230331: follow 1.69620230630: follow 1.55720230930: follow 1.69820231231: follow 1.81920240331: follow 1.68220240630: follow 1.74320240930: follow 1.63520241231: follow 1.62220250331: follow 1.72020250630: follow 1.70520250930: follow 2.06420251231: follow 2.059 0.77 1.51 2.25 20182019202020212022202320242025 Follow Universe

Quarterly compounding, invested quarters only · entry 47 days after quarter-end (when 13F data becomes public)

Listed as facts. See the verdict above before treating this as signal.

Top 20 holdings of 158 · 2026 Q1

Ticker Value Weight QoQ
MGA $2.0B
6.4%
TRIM
CTSH $1.2B
4.0%
ADD
TSN $1.1B
3.6%
ADD
BAX $1.1B
3.5%
TRIM
BMY $1.0B
3.4%
TRIM
CVS $989M
3.2%
TRIM
HUM $949M
3.1%
ADD
C $927M
3.0%
TRIM
SWKS $863M
2.8%
ADD
COF $836M
2.7%
TRIM
DOX $828M
2.7%
ADD
DG $819M
2.7%
TRIM
LEA $818M
2.7%
TRIM
UBS $816M
2.6%
TRIM
MET $799M
2.6%
TRIM
PPG $799M
2.6%
ADD
DOW $789M
2.6%
TRIM
GPN $782M
2.5%
HOLD
NOV $706M
2.3%
TRIM
WFC $698M
2.3%
TRIM

QoQ vs previous quarter's share count · NEW = new position · ADD/TRIM = ±2% shares · HOLD = unchanged.

Listed as facts. See the verdict above before treating this as signal.

New positions in 2026 Q1

Method & Limitations

Method: a "new position" = held this quarter, absent last quarter (options excluded; stocks with <50 prior holders excluded to filter spin-off artifacts). Entry 47 days after quarter-end — the first day the public could act on the filing. Benchmark = equal-weighted universe of all 13F-held stocks. Limitations: quarterly snapshots can't see intra-quarter trades; survivorship bias — funds that shut down are absent, which flatters the sample. Statistics, not advice.